Abstract
The diagnostic criteria for slowly progressive type 1 diabetes (slowly progressive insulin-dependent diabetes mellitus; SPIDDM) have been revised by the Committee on Type 1 Diabetes of the Japan Diabetes Society. All of the following three criteria must be met for “a definitive diagnosis of SPIDDM”: (1) presence of anti-islet autoantibodies at some point in time during the disease course; (2) absence of ketosis or ketoacidosis at the diagnosis of diabetes with no requirement of insulin treatment to correct hyperglycemia immediately after diagnosis in principle; and (3) gradual decrease of insulin secretion over time, with insulin treatment required at more than 3 months after diagnosis, and presence of severe endogenous insulin deficiency (fasting serum C-peptide immunoreactivity < 0.6 ng/mL) at the last observed point in time. When a patient fulfills the only (1) and (2), but not (3), he/she is diagnosed with “SPIDDM (probable)” because the diabetes is non-insulin-dependent state.
Original language | English |
---|---|
Pages (from-to) | 1-4 |
Number of pages | 4 |
Journal | Diabetology International |
Volume | 15 |
Issue number | 1 |
DOIs | |
State | Published - 2024/01 |
Keywords
- GAD antibody
- Latent autoimmune diabetes in adults
- SPIDDM
- Slowly progressive type 1 diabetes
- Type 1 diabetes
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism